Appointment Follows Israeli Ministry of Health Approval for Nexalin’s Gen-2 SYNC Device…
HOUSTON, TX, Nov. 13, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that it has entered into an exclusive dist… [4579 chars]
Source: GlobeNewswire | Published: 2025-11-13T00:00:00Z
Credit: GlobeNewswire
